Complementary Effect of Reflexology on Chemotherapy-Induced Nausea and Vomiting

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02653820

Enrollment

Registered

2016-01-12

Start date

2016-02-29

Completion date

2018-02-28

Last updated

2016-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reflexology

Brief summary

Reflexology treatment may influence the severity of chemotherapy-induced nausea and vomiting. This study aims to investigate the clinical effect of reflexology on chemotherapy-induced nausea and vomiting.

Interventions

OTHERReflexology

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Chemotherapy patients

Exclusion criteria

* Myocardial Infarction in previous 6 months * Mechanical colonic obstruction

Design outcomes

Primary

Measure	Time frame	Description
Change in Severity of Vomiting	Three weeks	Vomiting will be assessed both before after three weeks of reflexology treatment by Common Toxicity Criteria Adverse Events Tool
Change in Severity of Nausea	Three weeks	Nausea will be assessed both before after three weeks of reflexology treatment by Common Toxicity Criteria Adverse Events Tool

Countries

Israel

Contacts

Primary ContactKaterina Shulman, MD

katerinas@hy.health.gov.il972-4-6188280

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026